Atsushi Hayata

1.4k total citations
43 papers, 1.0k citations indexed

About

Atsushi Hayata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Atsushi Hayata has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 7 papers in Physiology. Recurrent topics in Atsushi Hayata's work include Cancer Immunotherapy and Biomarkers (12 papers), Cancer Cells and Metastasis (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Atsushi Hayata is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Cancer Cells and Metastasis (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Atsushi Hayata collaborates with scholars based in Japan and Norway. Atsushi Hayata's co-authors include Nobuyuki Yamamoto, Masanori Nakanishi, Hiroaki Akamatsu, Keiichiro Akamatsu, Yasuhiro Koh, Nahomi Tokudome, Hiroki Ueda, Kuninobu Kanai, Koichi Sato and Eriko Murakami and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Atsushi Hayata

38 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Atsushi Hayata 661 410 155 151 142 43 1.0k
Minako Nagai 804 1.2× 305 0.7× 166 1.1× 162 1.1× 90 0.6× 80 1.2k
Jiichiro Sasaki 775 1.2× 681 1.7× 308 2.0× 53 0.4× 89 0.6× 99 1.2k
Javier Gómez 361 0.5× 373 0.9× 270 1.7× 116 0.8× 39 0.3× 51 1.0k
N. Kramkimel 638 1.0× 148 0.4× 241 1.6× 103 0.7× 130 0.9× 45 970
Sojiro Kusumoto 522 0.8× 485 1.2× 349 2.3× 56 0.4× 50 0.4× 49 1.0k
Masahiro Iwasaku 782 1.2× 695 1.7× 221 1.4× 93 0.6× 49 0.3× 77 1.1k
Angelica Petrillo 551 0.8× 350 0.9× 233 1.5× 114 0.8× 46 0.3× 68 1.1k
Elena Ongaro 495 0.7× 304 0.7× 273 1.8× 53 0.4× 60 0.4× 38 878
David L. DeRemer 295 0.4× 129 0.3× 310 2.0× 139 0.9× 61 0.4× 64 1.1k
Youwei Bi 275 0.4× 307 0.7× 225 1.5× 55 0.4× 72 0.5× 25 768

Countries citing papers authored by Atsushi Hayata

Since Specialization
Citations

This map shows the geographic impact of Atsushi Hayata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Hayata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Hayata more than expected).

Fields of papers citing papers by Atsushi Hayata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Hayata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Hayata. The network helps show where Atsushi Hayata may publish in the future.

Co-authorship network of co-authors of Atsushi Hayata

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Hayata. A scholar is included among the top collaborators of Atsushi Hayata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Hayata. Atsushi Hayata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ozawa, Yuichi, Yasuhiro Koh, Ryota Shibaki, et al.. (2024). Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer. Cancer Immunology Immunotherapy. 74(1). 7–7. 4 indexed citations
2.
Akamatsu, Hiroaki, et al.. (2024). Invasive mucinous adenocarcinoma harbored MET exon 14 skipping mutation: case report. Translational Lung Cancer Research. 13(11). 3252–3255.
3.
Akamatsu, Hiroaki, Shunsuke Teraoka, Masanori Tanaka, et al.. (2023). A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients. Journal of Pain and Symptom Management. 67(3). 204–211.e1. 3 indexed citations
4.
Yoshioka, Y., Kouji Kobiyama, Tomoya Hayashi, et al.. (2023). A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component. Frontiers in Immunology. 14. 1116238–1116238. 6 indexed citations
5.
Kato, Mai, Daichi Fujimoto, Ryota Shibaki, et al.. (2023). Adjacent angle size correlates with diagnostic sensitivity of endobronchial ultrasonography with a guide sheath. Journal of Thoracic Disease. 15(11). 6019–6028. 1 indexed citations
6.
Ozawa, Yuichi, Eriko Murakami, Koichi Sato, et al.. (2022). Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors. Cancer Immunology Immunotherapy. 71(9). 2109–2116. 7 indexed citations
7.
Oyanagi, Jun, Yasuhiro Koh, Koichi Sato, et al.. (2021). Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors. Clinical Lung Cancer. 22(6). e833–e841. 4 indexed citations
8.
Akamatsu, Hiroaki, Shunsuke Teraoka, Hidetoshi Hayashi, et al.. (2021). Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study. JTO Clinical and Research Reports. 2(7). 100184–100184. 11 indexed citations
9.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors. Cancer Science. 111(5). 1468–1477. 109 indexed citations
10.
Hayata, Atsushi, et al.. (2019). Biological Effects of a Simplified Synthetic Analogue of Ion‐Channel‐Forming Polytheonamide B on Plasma Membrane and Lysosomes. Chemistry - A European Journal. 25(66). 15198–15204. 5 indexed citations
11.
Oyanagi, Jun, Yasuhiro Koh, Koichi Sato, et al.. (2019). Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab. Lung Cancer. 132. 107–113. 47 indexed citations
12.
Hayata, Atsushi, Hiroaki Itoh, & Masayuki Inoue. (2018). Solid-Phase Total Synthesis and Dual Mechanism of Action of the Channel-Forming 48-mer Peptide Polytheonamide B. Journal of the American Chemical Society. 140(33). 10602–10611. 15 indexed citations
13.
Sato, Koichi, Hiroaki Akamatsu, Eriko Murakami, et al.. (2017). Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab. Annals of Oncology. 28. ix86–ix86. 41 indexed citations
14.
Koh, Yasuhiro, Hiroaki Akamatsu, Kuninobu Kanai, et al.. (2017). Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients. PLoS ONE. 12(6). e0179744–e0179744. 36 indexed citations
15.
Tokudome, Nahomi, Hiroki Ueda, Masanori Nakanishi, et al.. (2016). Detection and management of everolimus associated pneumonitis with serum markers for interstitial pneumonia. Annals of Oncology. 27. vii101–vii101.
16.
Kikuchi, Takashi, Hiroaki Akamatsu, Keita Mori, et al.. (2016). Applicability of the Japanese equation for estimating glomerular filtration rate in patients with advanced-stage thoracic cancer. Respiratory Investigation. 54(6). 479–483.
17.
Oka, Asako, Kazuto Matsunaga, Tadashi Kamei, et al.. (2014). Ongoing Allergic Rhinitis Impairs Asthma Control by Enhancing the Lower Airway Inflammation. The Journal of Allergy and Clinical Immunology In Practice. 2(2). 172–178.e1. 39 indexed citations
18.
Matsunaga, Kazuto, Atsushi Hayata, Keiichiro Akamatsu, et al.. (2014). Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: A multicenter cross-sectional CAP study. Respiratory Investigation. 53(2). 82–85. 10 indexed citations
19.
Hayata, Atsushi, et al.. (1999). Hepatocyte Growth Factor Concentration in Rat Bile Is Affected by Hepatic Resection Volume and External Biliary Drainage. Journal of Surgical Research. 85(1). 71–76. 5 indexed citations
20.
Kurumiya, Yasuhiro, Yuji Nimura, Eiji Takeuchi, et al.. (1999). Active form of human hepatocyte growth factor is excreted into bile after hepatobiliary resection. Journal of Hepatology. 30(1). 22–28. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minako Nagai Breakdown of academic impact, for papers by Jiichiro Sasaki Breakdown of academic impact, for papers by Javier Gómez Breakdown of academic impact, for papers by N. Kramkimel Breakdown of academic impact, for papers by Sojiro Kusumoto Breakdown of academic impact, for papers by Masahiro Iwasaku Breakdown of academic impact, for papers by Angelica Petrillo Breakdown of academic impact, for papers by Elena Ongaro Breakdown of academic impact, for papers by David L. DeRemer Breakdown of academic impact, for papers by Youwei Bi
Rankless by CCL
2026